Hyaluronic acid is an unbranched high molecular weight polysaccharide, consisting of repeating disaccharide units of glucuronate-1, 3N acetyl glucosamine linked by [1] [2] [3] [4] bonds.
The introduction of sensitive assays has now made it possible to detect HA in very low concentrations (Engstrom- Laurent et al., 1985a; Delpech et al., 1985) . Tissue HA enters the circulation via the lymph and is rapidly extracted and catabolised by the liver (Laurent & Fraser, 1986) , resulting in a normal serum HA level of 10-lOO1 gl-1. The level of HA can rise in cirrhosis (Engstrom-Laurent et al., 1985b) and rheumatoid arthritis (Engstrom-Laurent & Hillgren, 1985) and in end stage renal failure .
There have been a few reports of raised serum levels of HA in advanced cancer; Delpech et al. (1985) made this observation when developing their enzymoimmunologic assay. Later they used this test to investigate the HA concentrations in the serum and pleural effusions in mesothelioma and observed high levels in advanced disease (mean 750 pgl-1; range 833 Mgl -1), but the test was unsuitable for early diagnosis (Frebourg et al., 1987) . Manley & Warren (1987) using a nephelometric assay also observed raised serum HA levels in cancer, but their technique gave much higher concentrations for normal HA levels (mean l.O9mgl-1; range 0-4mgl-1).
The availability of a commercial radiometric (HA test 50, Pharmacia, Uppsala, Sweden) has provided an opportunity to extend these preliminary observations. This assay has been developed from the method described by Tengblad (1980) and Laurent & Tengblad (1980) . The test is based on the use of specific hyaluronic acid binding proteins, (HABP) isolated from bovine cartilage. First the hyaluronic acid from the sample is allowed to bind 1 251-labelled HABP in solution for at least 60min. The unbound 125J-HABP is then quantitated by incubating with HA covalently coupled to sepharose particles of small size and low density. The particles stay suspended during the 45 min incubation. Separation is performed by centrifugation followed by decanting. The radioactivity bound to the particles is measured. It is inversely proportional to the concentration of HA in the sample. The assay has a detection limit of <5,pgl-, and an operating range of <5-500 pgl-1. The coefficient of variation within and between assays was 6.5 and 4.9% respectively for a sample with a mean value of 29.Opgl-, 5.2 and 8.0% respectively for a sample with a mean value of 312 pugl-1. with all stages. The molecular weight distribution of HA in the sera of 2 patients with Wilms' tumours was analysed by high performance gel chromatography (Superose 6, Pharmacia). Both samples showed that the predominant form of HA was a high molecular weight polymer (>106 kD) and this was associated with a wide range of smaller polymers tõ 104kD (Figure 2 ).
These studies confirm that a raised serum HA may accompany malignant disease but cannot be considered as a I Br. J. Cancer (1988), 58, 668-669 * *-. I and II  19  8  5  5  1  III and IV  13  3  3  3  4  Neuroblastoma  III and IV  18  15  3 tumour marker. The results suggest that this phenomenon is particular to individual patients and generalisations cannot be made about the effects of the metastatic involvement of a particular tissue, as shown by the lack of elevation of the median levels in cancers with skeletal metastases and myelomatosis, or in patients with hepatic metastases. HA is normally cleared very rapidly from the circulation, mostly by the liver with a minor fraction of lower molecular weight polymer metabolised by the kidney . Whilst cirrhosis is associated with a raised serum HA, metastatic cancer involving the liver rarely produces severely reduced liver function. Nevertheless, a rise can be observed in individual patients with time, and probably comes from the overproduction of HA by certain tumours. As yet, the mechanism of increased serum levels of HA in cancer is unclear. However, there are some clues from the case reports. Greatly increased levels of serum HA have been observed in Wilms' tumour (Powars et al., 1972; Wu et al., 1984; Ater et al., 1984; Bracey et al., 1987) and neuroblastoma (Broughton et al., 1970) . In a few patients the rise of serum HA was associated with increased viscosity. These reports were based on relatively insensitive chemical assays but pointed out that certain tumours have a great propensity for HA synthesis. Our results using a sensitive radiometric assay indicate that abnormal HA production is associated with about two thirds of Wilms' tumours; the precise nature of this phenomenon at the cellular level is still to be investigated.
